Allogeneic hematopoietic cell transplantation in acute myeloid leukemia with normal karyotype and isolated Nucleophosmin-1 (NPM1) mutation: outcome strongly correlates with disease status

Affiliations

• ¹ Department of Internal Medicine, Bone Marrow Transplantation Program, American University of Beirut Medical Center, Beirut bazarbac@aub.edu.lb.
• ² EBMT Paris study office / CEREST-TC, France Department of Hematology, Saint Antoine Hospital, Paris, France INSERM UMR 938, Paris, France Université Pierre et Marie Curie, Paris, France.
• ³ Department of Internal Medicine, Bone Marrow Transplantation Program, American University of Beirut Medical Center, Beirut Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center/University of South Florida College of Medicine, Tampa, Florida.
• ⁴ Deutsche Klinik für Diagnostik KMT Zentrum, Wiesbaden, Germany.
• ⁵ Department of Medicine, Helsinki, Finland.
• ⁶ Gustave Roussy, institut de cancérologie, BMT Service, Division of Hematology, Department of Medical Oncology, Villejuif, France.
• ⁷ Hopital St. Louis, Dept.of Hematology - BMT, Paris, France.
• ⁸ Hopital Jean Minjoz, Service d' Hématologie, Besancon, France.
• ⁹ Rikshospitalet Department of Medicine, The National Hospital, Oslo, Norway.
• ¹⁰ Azienda Ospedaliera Papa Giovanni XXIII Hematology and Bone Marrow Transplant Unit, Bergamo, Italy.
• ¹¹ Charles University Hospital, Dept. of Hematology/Oncology, Pilsen, Czech Republic.
• ¹² Klinikum Augsburg II Medizinische Klinik, Augsburg, Germany.
• ¹³ Programme de Transplantation & Therapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, Marseille, France.
• ¹⁴ CHU Nantes Dept. D'Hématologie, Nantes, France;
• ¹⁵ SCT Unit, Klinikum Augsburg, Germany;
• ¹⁶ Department of Hematology, Hospital Clinic, IDIBAPS, Barcelona, Spain.
• ¹⁷ EBMT Paris study office / CEREST-TC, France Tel Aviv University, Chaim Sheba Medical Center, Tel-Hashomer, Israel.